Contribution: Industrial Research Assistance Program – Contributions to Firms
Medscint inc.
$75,000.00
ARP - Use of the Hyperscint platform for in vivo surface dosimetry during radiotherapy treatments
FY 2024-25 · 2024-09-23
Summary
This project will investigate the technological uncertainties involved in using the Hyperscint MD product for in vivo surface dosimetry during external radiotherapy treatments.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Quebec|Québec, Quebec, Canada
Recipient Type
For-profit organization
Business Number
748576287
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2025-03-28
Agreement Number
1022390
Agreement Start Date
2024-09-23
Agreement Title
ARP - Use of the Hyperscint platform for in vivo surface dosimetry during radiotherapy treatments
Agreement Title (French)
PRA - Utilisation de la plateforme Hyperscint pour la dosimétrie in vivo superficielle lors des traitements de radiothérapie
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will investigate the technological uncertainties involved in using the Hyperscint MD product for in vivo surface dosimetry during external radiotherapy treatments.
Description (French)
Ce projet permettra d’étudier les incertitudes technologiques liées à l’utilisation du produit Hyperscint MD pour un usage de dosimétrie in vivo de surface pendant les traitements de radiothérapie externe.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Québec
Federal Riding (French)
Québec
Federal Riding Number
24059
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
748576287
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Medscint inc.
Recipient Postal Code
G1P 4P5
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2024-2025-Q2-1022390
